Study Claims Ozempic Lowers Biological Age
Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
GLP-1 medications have proven to be incredibly versatile, originally developed as a treatment for diabetes, and later used for treating obesity and promoting weight loss.
A recent 32-week, double-blind, placebo-controlled trial by TruDiagnostic suggests that Ozempic may reduce the user’s biologic age by just over three years.
Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
Author's summary: Ozempic reduces biological age.
More News
- Giving States Waivers From Accountability Is a Dangerous Step Backward for Kids
- Elon Musk's xAI Launches Grok-powered 'Grokipedia' Encyclopedia
- TCT 2025: ShortCUT Trial Compares Cutting Balloon Angioplasty and Intravascular Lithotripsy (IVL) for Calcified Coronary Artery Disease
- Officials Plan to Set Fire to Vegetation Around Lake Tahoe This Week — and They Have a Good Reason
- Grokipedia launches after brief crash, accused of copying Wikipedia content - Tech Digest
- Store your passport in Apple Wallet, don’t get locked out of your X account, researchers reveal sycophantic nature of AI | Tech Today - Video
- US passport support in Apple Wallet is a hugely important step
- Ultra Pure Water Management in Semiconductor Manufacturing: Insights on Reuse and Quality Control
- Some ‘Loser’ National Parks Could Soon Have Their NPS Status Taken Away, Congressman Announced
- MLB: The Last 10 World Series MVPs